RE:RE:RE:RE:Anything North of $130 is a homerun!ProfCornelius wrote: Earnings are the name of the game here but we better show sustainable growth especially with the trst patient and supply voids to fill. I am %100 positive that we capitalized on the trst opportunity !! We basically sold anything and everything that we could produce in Q12020. That is a fact PROF
Thewanderer wrote: Prof, 135ish could still be good for a big rise ONLY if increased profits somehow.
But I’m pretty sure we will do 140
or above. Surely rec marijuana sales will be record sales this quarter due to Aphria one full scale and confirmed higher all around weed sales this summer according to stats Canada - Can’t find the link right now. Really hoping we got a nice chunk of unexpected sales from Canntrust.
ProfCornelius wrote: Hello Viper,
The analysts are coming in around 138M CDN so we need to do better than 130M CDN.
Nice quiet board today, great to see.
I'm coming in with 110M CDN for CC Pharma like Leggy and another poster.
Latam is a wild card???
I'll give you my REC estimate a little later this week.
August 30/19, the last day of Q12020 we traded at $8.39 which is $0.54 CDN lower than the last trading day of Q42019. May 31/19 we traded $8.93 so closing $0.54 CDN lower at the end of Q12020 will bolster our earnings as well.
PROF
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ Viper31 wrote: My prediction is like many others here. $140 to $150 range!!! Again anything above $130 is a homerun. North of $150 is a grandslam. Also think if we got DD this friday and $130+ on tuesday morning?????? I say the dust will be blown off that bottle I been waiting to drink and celebrate for a while.
Viper
Stats Can has reported nationwide sales over the past quarter on an average of $100M per month. Aproxiamately $300 for the quarter. I believe APHA has 10-15% market share. Keeping this in mind plus TRST sales captured plus CC Pharma plus LATAM plus Aleafia wholesale contract, I believe we will exceed $150M.